SIMG
ABMD

Stephens Investment Management Group’s Abiomed Inc ABMD Stock Holding History

Stephens Investment Management Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,630
Closed -$5.07M – 173
2022
Q3 		$5.07M Buy
20,630
+1,385
+7% +$374K 0.1% 147
2022
Q2 		$4.76M Sell
19,245
-830
-4% -$224K 0.09% 147
2022
Q1 		$6.65M Buy
20,075
+25
+0.1% +$7.7K 0.1% 147
2021
Q4 		$7.2M Sell
20,050
-801
-4% -$271K 0.09% 160
2021
Q3 		$6.79M Sell
20,851
-18
-0.1% -$6.1K 0.09% 161
2021
Q2 		$6.51M Buy
20,869
+1,013
+5% +$311K 0.09% 159
2021
Q1 		$6.33M Buy
19,856
+2,349
+13% +$752K 0.09% 156
2020
Q4 		$5.68M Sell
17,507
-307
-2% -$84.9K 0.08% 156
2020
Q3 		$4.94M Buy
17,814
+1,822
+11% +$525K 0.09% 152
2020
Q2 		$3.86M Buy
+15,992
New +$3.21M 0.07% 152
2020
Q1 		– Sell
-108,207
Closed -$18.5M – 169
2019
Q4 		$18.5M Sell
108,207
-3
-0% -$556 0.35% 104
2019
Q3 		$19.2M Sell
108,210
-51,958
-32% -$11.2M 0.39% 101
2019
Q2 		$41.7M Buy
160,168
+1,519
+1% +$403K 0.79% 56
2019
Q1 		$45.3M Buy
158,649
+1,294
+0.8% +$430K 0.92% 43
2018
Q4 		$51.1M Sell
157,355
-2,985
-2% -$1.04M 1.21% 20
2018
Q3 		$72.1M Sell
160,340
-56,735
-26% -$22.4M 1.33% 11
2018
Q2 		$89.9M Sell
217,075
-40,891
-16% -$14.8M 1.81% 1
2018
Q1 		$75.1M Sell
257,966
-46,282
-15% -$11.7M 1.63% 4
2017
Q4 		$57M Sell
304,248
-14,446
-5% -$2.7M 1.3% 13
2017
Q3 		$53.7M Buy
318,694
+2,443
+0.8% +$369K 1.24% 20
2017
Q2 		$45.3M Buy
316,251
+1,501
+0.5% +$202K 1.09% 25
2017
Q1 		$39.4M Buy
314,750
+22,545
+8% +$2.61M 0.97% 32
2016
Q4 		$32.9M Buy
292,205
+19,964
+7% +$2.31M 0.92% 37
2016
Q3 		$35M Buy
272,241
+9,763
+4% +$1.17M 1.04% 29
2016
Q2 		$28.7M Sell
262,478
-1,627
-0.6% -$162K 0.94% 36
2016
Q1 		$25M Buy
264,105
+23,550
+10% +$1.99M 0.88% 42
2015
Q4 		$21.7M Sell
240,555
-7,060
-3% -$599K 0.77% 48
2015
Q3 		$23M Sell
247,615
-11,100
-4% -$978K 0.81% 45
2015
Q2 		$17M Buy
258,715
+133,080
+106% +$8.84M 0.5% 87
2015
Q1 		$8.99M Buy
+125,635
New +$6.82M 0.27% 129

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Stephens Investment Management Group's ABMD Position: Q4 2022 in Review

Stephens Investment Management Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 20,630 shares — an estimated $5.07M sold.

Stephens Investment Management Group first reported a position in ABMD in Q1 2015 and held it in 30 quarters. The position peaked at $89.9M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Stephens Investment Management Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Stephens Investment Management Group sold 20,630 Abiomed Inc shares in Q4 2022, an estimated $5.07M.
  • Stephens Investment Management Group first reported a position in Abiomed Inc in Q1 2015 and held it in 30 quarters.
  • Stephens Investment Management Group's Abiomed Inc position peaked at $89.9M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Stephens Investment Management Group's 13F filing for Q4 2022, filed 26 Jan 2023.